The GMP certificate will allow the manufacturing site in Hervás, Cáceres to manufacture active ingredients for the pharmaceutical industry that is based on medicinal plants
Wacker Biotech will manufacture the active ingredients of MinervaX’s novel vaccine candidate
This existing GMP compliant facility, located at Bharuch (Unit-1) with ongoing expansion part of the company's strategic capex initiative
Ashland's nutraceuticals business supplies a broad portfolio of active ingredients and formulation aids to nutritional product companies
NexGard Spectra is a soft, flavourful monthly chew that kills fleas before they can lay eggs
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
Oteseconazole Capsules were found to be safe and more effective than fluconazole
Subscribe To Our Newsletter & Stay Updated
